| CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian … JS Nielsen, RA Sahota, K Milne, SE Kost, NJ Nesslinger, PH Watson, ... Clinical cancer research 18 (12), 3281-3292, 2012 | 585 | 2012 |
| The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature RJ Deleeuw, SE Kost, JA Kakal, BH Nelson Clinical cancer research 18 (11), 3022-3029, 2012 | 539 | 2012 |
| Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer NR West, SE Kost, SD Martin, K Milne, RJ Deleeuw, BH Nelson, ... British journal of cancer 108 (1), 155-162, 2013 | 320 | 2013 |
| Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007–2009 study KA Nichol, HJ Adam, Z Hussain, MR Mulvey, M McCracken, LF Mataseje, ... Diagnostic microbiology and infectious disease 69 (3), 320-325, 2011 | 74 | 2011 |
| CD25 Identifies a Subset of CD4+FoxP3− TIL That Are Exhausted Yet Prognostically Favorable in Human Ovarian Cancer RJ DeLeeuw, DR Kroeger, SE Kost, PP Chang, JR Webb, BH Nelson Cancer immunology research 3 (3), 245-253, 2015 | 60 | 2015 |
| Transcriptome atlas of the Arabidopsis funiculus–a study of maternal seed subregions D Khan, JL Millar, IJ Girard, A Chan, RC Kirkbride, JM Pelletier, S Kost, ... The Plant Journal 82 (1), 41-53, 2015 | 39 | 2015 |
| Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005–06 LF Mataseje, J Xiao, S Kost, LK Ng, K Dore, MR Mulvey, ... Journal of antimicrobial chemotherapy 64 (4), 723-730, 2009 | 28 | 2009 |
| Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia SEF Kost, EDJ Bouchard, É LaBossière, X Ye, ML Queau, WS Liang, ... Leukemia Research 50, 63-71, 2016 | 11 | 2016 |
| Behavioral effects of elevated expression of human equilibrative nucleoside transporter 1 in mice S Kost, C Sun, W Xiong, K Graham, CE Cass, JD Young, BC Albensi, ... Behavioural brain research 224 (1), 44-49, 2011 | 10 | 2011 |
| Transcriptional modulation by idelalisib synergizes with bendamustine in chronic lymphocytic leukemia SEF Kost, A Saleh, EM Mejia, M Mostafizar, EDJ Bouchard, V Banerji, ... Cancers 11 (10), 1519, 2019 | 6 | 2019 |
| A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia G Ishdorj, SEF Kost, S Beiggi, Y Zang, SB Gibson, JB Johnston Leukemia Research 59, 66-74, 2017 | 6 | 2017 |
| Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines G Ishdorj, Z Nugent, M Squires, S Kost, V Banerji, L Davidson, CS Katyal, ... Leukemia Research 109, 106628, 2021 | 4 | 2021 |
| High cumulative illness rating scale (CIRS) score in CLL correlates with short CLL telomere length and decreased survival L Yang, S Beiggi, Y Zhang, S Kost, R Schmidt, G Ishdorj, DHS Dhaliwal, ... Blood 128 (22), 4362, 2016 | 2 | 2016 |
| Venetoclax inhibits autophagy in chronic lymphocytic leukemia cells Y Chen, SEF Kost, X Yang, V Banerji, JB Johnston, S Katyal, SB Gibson Autophagy Reports 2 (1), 2169518, 2023 | 1 | 2023 |
| Buccal cell telomere length is not a useful marker for comorbidities in chronic lymphocytic leukemia L Yang, SEF Kost, S Beiggi, Y Zhang, R Schmidt, Z Nugent, A Marshall, ... Leukemia research 86, 106220, 2019 | 1 | 2019 |
| DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease SEF Kost, A Saleh, SH Yuan, B Kuzio, SB Gibson, L Yang, V Banerji, ... Blood Cancer Journal 13 (1), 20, 2023 | | 2023 |
| Transcriptional modulation by idelalisib synergizes with bendamustine in chronic lymphocytic leukemia S Kost, A Saleh, E Mejia, M Mostafizar, E Bouchard, V Banerji, A Marshall, ... LEUKEMIA & LYMPHOMA 61, 44-45, 2020 | | 2020 |
| Cross-resistance and synergy between idelalisib and bendamustine in chronic lymphocytic leukemia SEF Kost, A Saleh, EM Mejia, M Mostafizar, EDJ Bouchard, V Banerji, ... Cancer Research 78 (13_Supplement), 1891-1891, 2018 | | 2018 |
| A unique spliced isoform of TIN2 is expressed in chronic lymphocytic leukemia G Ishdorj, S Gibson, S Kost, J Johnston, S Beiggi LEUKEMIA & LYMPHOMA 58, 216-217, 2017 | | 2017 |
| Effect of age and co-morbidities on telomere length and disease aggressiveness in chronic lymphocytic leukemia L Yang, J Johnston, S Beiggi, S Kost, R Schmidt, Y Zhang, G Ishdorj, ... LEUKEMIA & LYMPHOMA 58, 231-231, 2017 | | 2017 |
